Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Cardiovascular events | |||||
[103]
RCT 3-armed trial |
9794 people with MI, left ventricular ejection fraction (LVEF) <0.40, or clinical heart failure |
Cardiovascular mortality or heart failure
1331/4885 (27.2%) with valsartan plus captopril 1335/4909 (27.2%) with captopril alone |
HR 1.00 97.5% CI 0.92 to 1.09 P = 0.94 |
Not significant | |
[104]
RCT 3-armed trial |
17,078 people with vascular disease |
Cardiovascular mortality, MI, stroke, or hospital admission for heart failure
1386/8502 (16.3%) with telmisartan plus ramipril 1412/8576 (16.5%) with ramipril alone |
RR 0.99 95% CI 0.92 to 1.07 |
Not significant | |
[104]
RCT 3-armed trial |
17,078 people with vascular disease |
Fatal and non-fatal MI
438/8502 (5.2%) with telmisartan plus ramipril 413/8576 (4.8%) with ramipril alone |
RR 1.08 95% CI 0.94 to 1.23 |
Not significant | |
Adverse events | |||||
[103]
RCT 3-armed trial |
9794 people with MI, LVEF <0.40, or clinical heart failure |
Withdrawal because of adverse effects
438/4862 (9%) with valsartan plus captopril 375/4879 (8%) with captopril alone |
P <0.05 |
Effect size not calculated | captopril alone |
[103]
RCT 3-armed trial |
9794 people with MI, LVEF <0.40, or clinical heart failure |
Withdrawal because of hypotension
90/4862 (2%) with valsartan plus captopril 41/4879 (1%) with captopril alone |
P <0.05 |
Effect size not calculated | captopril alone |
[104]
RCT 3-armed trial |
17,118 people with vascular disease |
Withdrawal because of hypotension
406/8502 (5%) with telmisartan plus ramipril 149/8576 (2%) with ramipril alone |
P <0.001 |
Moderate effect size | ramipril alone |
[103]
RCT 3-armed trial |
9794 people with MI, LVEF <0.40, or clinical heart failure |
Withdrawal because of hyperkalaemia
12/4862 (0.2%) with valsartan plus captopril 4/4879 (0.1%) with captopril alone |
Not significant | ||
[104]
RCT 3-armed trial |
17,118 people with vascular disease |
Hyperkalaemia (potassium >5.6 mmol/L)
480/8502 (6%) with telmisartan plus ramipril 283/8576 (3%) with ramipril alone |
P <0.001 |
Moderate effect size | ramipril alone |